Pure Global AI
NCT05832307Not yet recruiting

The INFLUENTIAL Trial- Evaluation of National Inpatient Influenza Vaccination Program

The INFLUENTIAL Trial - Inpatient FLU Vaccination Program Effectiveness: National Trial Implementing Best Practices and Learning Collaboratives
University of Colorado, DenverClinicalTrials.govother
Verified
Study focus
Disease/Condition
Influenza
Drug/Device/Intervention
Existing Influenza Vaccination Practices
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
University of Colorado, Denver
Timeline & enrollment
Phase
N/A
Start date
Apr 17, 2023
End date
Jul 31, 2027
Enrollment
22000 participants
Primary outcome

Vaccine administration rate

Summary

This study plans to learn more about whether a stakeholder-informed, standardized inpatient
 vaccination program will increase influenza vaccination rates of hospitalized children across
 US pediatric health systems. The first part of the study is to form a multidisciplinary team
 of stakeholders, including parents, providers, nurses, pharmacists, informaticists, data
 analysts and communication experts across three sites in synthesizing a best practice
 implementation guide for an inpatient influenza vaccination program, which will then be
 piloted at these three sites.

ICD-10 classifications
Influenza and pneumoniaInfluenza due to identified seasonal influenza virusInfluenza with other manifestations, seasonal influenza virus identifiedInfluenza with pneumonia, seasonal influenza virus identifiedInfluenza due to identified zoonotic or pandemic influenza virus
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05832307
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05832307 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Colorado, Denver and is currently Not yet recruiting. The study focuses on Influenza. Target enrollment is 22000 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.